CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Congenital Abnormalities D000013 11 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Anemia D000740 21 associated lipids
Arteriosclerosis D001161 86 associated lipids
Asthma D001249 52 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Birth Weight D001724 23 associated lipids
Body Weight D001835 333 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Carcinoma 256, Walker D002279 22 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Chancroid D002602 4 associated lipids
Chondrosarcoma D002813 9 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
O'Flaherty JT et al. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. 1981 Am. J. Pathol. pmid:6274199
Aikawa M et al. Interactions between macrophagelike cells and Leishmania braziliensis in vitro. 1982 Am. J. Pathol. pmid:7091302
Elbim C et al. Heterogeneity in Lewis-X and sialyl-Lewis-X antigen expression on monocytes in whole blood: relation to stimulus-induced oxidative burst. 1998 Am. J. Pathol. pmid:9546369
Fantone JC et al. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. 1984 Am. J. Pathol. pmid:6324595
Okayasu T et al. Cytochalasin delays but does not prevent cell death from anoxia. 1984 Am. J. Pathol. pmid:6541879
Becker EL et al. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187. 1979 Am. J. Pathol. pmid:219701
O'Flaherty JT et al. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. 1981 Am. J. Pathol. pmid:7223864
O'Flaherty JT et al. Substances which aggregate neutrophils. Mechanism of action. 1978 Am. J. Pathol. pmid:356621
Hsu LS and Becker EL Volume changes induced in rabbit polymorphonuclear leukocytes by chemotactic factor and cytochalasin B. 1975 Am. J. Pathol. pmid:1180327
Ulevitch RJ et al. Hyperexpression of interferon-gamma-induced MHC class II genes associated with reorganization of the cytoskeleton. 1991 Am. J. Pathol. pmid:1907805
Ogawa H et al. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release. 1981 Am. J. Pathol. pmid:7294162
O'Flaherty JT et al. Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. 1981 Am. J. Pathol. pmid:6271016
Holland JA et al. Atherogenic levels of low-density lipoprotein increase endocytotic activity in cultured human endothelial cells. 1992 Am. J. Pathol. pmid:1546741
Mease AD et al. Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response. 1981 Am. J. Pathol. pmid:7258298
White JG and Rao GH Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. 1998 Am. J. Pathol. pmid:9466587
Mukherjee C and Lynn WS Role of ions and extracellular protein in leukocyte motility and membrane ruffling. 1978 Am. J. Pathol. pmid:717536
Schollmeyer JV et al. An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. 1978 Am. J. Pathol. pmid:717537
Webster RO et al. Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a. 1986 Am. J. Pathol. pmid:3789092
Ginsberg M et al. Mechanisms of platelet response to monosodium urate crystals. 1979 Am. J. Pathol. pmid:426039
White JG et al. Glycoprotein Ib is homogeneously distributed on external and internal membranes of resting platelets. 1999 Am. J. Pathol. pmid:10595941